eli lilly's tirzepatide is the leader in weight loss sector Zepbound Tops Novo Nordisk's Wegovy Weight-Loss Trial Eli Lilly weight loss drug

Data extraction was conducted by two independent reviewers, with discrepancies resolved by a third reviewer

Dual Agonist Therapies Fundamentally, tirzepatide and semaglutide work by mimicking natural hormones that regulate appetite and blood sugar

Meaningful appetite suppression typically begins at 5.0 mg, with significant weight loss acceleration happening at 10.0 mg and above

A 2.5 mg dose of tirzepatide and a 0.25 mg dose of semaglutide are both "starting doses" that serve the same purpose, tolerance building, but the actual pharmacology behind each number is unique

You may have heard of it by its brand names, Zepbound or Mounjaro